<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title> MD 安德森研究人员报告了针对白血病的新型 Menin 靶向疗法的早期成功</title><description>由德克萨斯大学 MD 安德森癌症中心的研究人员领导的两项临床试验表明，针对 menin 的新疗法用于治疗具有特定基因改变的复发性或难治性急性白血病的早期积极结果。</description><link/> https://www.news-medical.net/news/20231211/MD-Anderson-researchers-report-early-success-of-novel-menin-targeted-therapies-in-leukemia.aspx<comments> https://www.news-medical.net/news/20231211/MD-Anderson-researchers-report-early-success-of-novel-menin-targeted-therapies-in-leukemia.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=e99fc922-58b0-4eb4-88a6-321cc1fde05b</guid><pubDate> Mon, 11 Dec 2023 15:04:09 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/6/red_blood_cells-620x480.jpg" width="620"><media:description><![CDATA[MD Anderson researchers report early success of novel menin-targeted therapies in leukemia]]></media:description></media:content></item><item><title>靶向治疗可减少疾病负担标志物，改善非晚期系统肥大细胞增多症患者的症状</title><description>根据德克萨斯大学 MD 安德森癌症中心研究人员报告的 II 期 SUMMIT 试验结果，靶向治疗 bezuclastinib 是安全的，可以快速降低疾病负担标志物，同时还能改善患有一种称为非高级系统肥大细胞增多症的罕见血液疾病的患者的症状。</description><link/> https://www.news-medical.net/news/20231211/Targeted-therapy-reduces-markers-of-disease-burden-improves-symptoms-for-病人-with-nonadvanced-system-mastocytosis.aspx<comments> https://www.news-medical.net/news/20231211/Targeted-therapy-reduces-markers-of-disease-burden-improves-symptoms-for-病人-with-nonadvanced-system-mastocytosis.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=56232a96-f127-46f3-ac33-8c8eeb50867b</guid><pubDate> Mon, 11 Dec 2023 15:02:25 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/92036744-620x480.jpg" width="620"><media:description><![CDATA[Targeted therapy reduces markers of disease burden, improves symptoms for patients with nonadvanced system mastocytosis]]></media:description></media:content></item><item><title>新药物组合使骨髓纤维化患者缩小肿大脾脏的效果加倍</title><description>对于患有中度或高危骨髓纤维化的成人患者，将 JAK 抑制剂鲁索替尼与 BCL-xL 抑制剂 navitoclax 联合使用，在减少脾脏肿大（临床改善的主要指标）方面的效果是标准护理鲁索替尼单药疗法的两倍，中度或高危骨髓纤维化是一种罕见的骨髓纤维化。根据德克萨斯大学 MD 安德森癌症中心研究人员报告的 III 期 TRANSFORM-1 试验结果，骨髓癌。</description><link/> https://www.news-medical.net/news/20231211/New-drug-combination-doubles-effectness-in-shrinking-enlarged-spleens-in-myelofibrosis- Patients.aspx<comments> https://www.news-medical.net/news/20231211/New-drug-combination-doubles-effectness-in-shrinking-enlarged-spleens-in-myelofibrosis- Patients.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=cd08f87e-2643-4c7a-a1f5-4f0ad2177af3</guid><pubDate> Mon, 11 Dec 2023 14:55:44 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/4/Test_tubes_filled_with_blood_in_laboratory-Africa_Studio_90df34ad51cd439690eb2cabb696156a-620x480.jpg" width="620"><media:description><![CDATA[New drug combination doubles effectiveness in shrinking enlarged spleens in myelofibrosis patients]]></media:description></media:content></item><item><title>达沙替尼和 blinatumomab 的组合为老年 Ph+ ALL 患者提供了有效的治疗</title><description>费城染色体阳性 (Ph+) 急性淋巴细胞白血病 (ALL) 老年患者不适合强化化疗标准治疗，但采用达沙替尼和博纳吐莫单抗替代方案后，中位总生存期 (OS) 为 6.5 年。</description><link/> https://www.news-medical.net/news/20231211/Combination-of-dasatinib-and-blinatumomab-offers- effective-treatment-for-older-Ph2b-ALL-病人.aspx<comments> https://www.news-medical.net/news/20231211/Combination-of-dasatinib-and-blinatumomab-offers- effective-treatment-for-older-Ph2b-ALL-病人.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8db9a5b6-7569-478c-b1c8-93cec5de1292</guid><pubDate> Mon, 11 Dec 2023 14:52:40 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Chemo_Vials-620x480.jpg" width="620"><media:description><![CDATA[Combination of dasatinib and blinatumomab offers effective treatment for older Ph+ ALL patients]]></media:description></media:content></item><item><title>新型 CAR T 细胞疗法 AT101 的 I 期临床试验显示出有希望的早期反应</title><description>研究人员表示，AT101 是一种新型 CAR T 细胞疗法，使用独特的结合机制来靶向 CD19，其 I 期临床试验的早期结果显示，在试验中研究的较高剂量水平下，完全缓解 (CR) 率为 100%来自宾夕法尼亚大学佩雷​​尔曼医学院和宾夕法尼亚大学医学院艾布拉姆森癌症中心。</description><link/> https://www.news-medical.net/news/20231211/Phase-I-clinical-trial-of-new-CAR-T-cell-therapy-AT101-shows-promising-early-responses.aspx<comments> https://www.news-medical.net/news/20231211/Phase-I-clinical-trial-of-new-CAR-T-cell-therapy-AT101-shows-promising-early-responses.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=e1e3b1a4-ee1d-47ab-93a0-93ec3b34c3cf</guid><pubDate> Mon, 11 Dec 2023 14:50:47 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/6/Anatomical_structure_of_biological_animal_cell_with_organelles-eranicle_1d73b50575dc4546875a4a2fc7d429a6-620x480.jpg" width="620"><media:description><![CDATA[Phase I clinical trial of new CAR T cell therapy AT101 shows promising early responses]]></media:description></media:content></item><item><title> 440 万美元赠款推动电子病历中健康数据社会决定因素的标准化</title><description>LOINC 和 Regenstrief Institute 的健康数据标准已获得 Regenstrief 基金会提供的 440 万美元赠款，用于支持扩展一项全球倡议的工作，该倡议将健康的社会决定因素 (SDOH) 信息分类和标准化到电子健康记录 (EHR) 中，这是一个雄心勃勃的项目将社会需求数据整合到临床护理中，以更有效地解决健康不平等问题。</description><link/> https://www.news-medical.net/news/20231211/2444-million-grant-drives-forward-standardization-of-social-determinants-of-health-data-in-EHRs.aspx<comments> https://www.news-medical.net/news/20231211/2444-million-grant-drives-forward-standardization-of-social-determinants-of-health-data-in-EHRs.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=589caef3-75ca-40f8-85ce-317e477fa78b</guid><pubDate> Mon, 11 Dec 2023 11:12:14 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Stress-620x480.jpg" width="620"><media:description><![CDATA[$4.4 million grant drives forward standardization of social determinants of health data in EHRs]]></media:description></media:content></item><item><title>赋权社区：“用心了解糖尿病”倡议授予抗击心血管疾病的赠款</title><description>美国糖尿病协会和美国心脏协会已向 10 个社区组织提供赠款，帮助 2 型糖尿病患者降低心脏病、心力衰竭和中风等心血管疾病的风险。</description><link/> https://www.news-medical.net/news/20231211/Empowering-communities-Know-Diabetes-by-Heart-initiative-awards-grants-to-combat-cardioangio-disease.aspx<comments> https://www.news-medical.net/news/20231211/Empowering-communities-Know-Diabetes-by-Heart-initiative-awards-grants-to-combat-cardioangio-disease.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=bc21513c-c6db-4971-813f-d739f69db4e0</guid><pubDate> Mon, 11 Dec 2023 11:08:28 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Insulin-620x480.jpg" width="620"><media:description><![CDATA[Empowering communities: Know Diabetes by Heart initiative awards grants to combat cardiovascular disease]]></media:description></media:content></item><item><title>天然化合物激活巨噬细胞对抗耐药结核菌</title><description>结核病 (TB) 是一种流行的传染病，每年影响数百万人。在 COVID-19 大流行之前，它曾是单一病原体导致死亡的主要原因。</description><link/> https://www.news-medical.net/news/20231211/Natural-compound-activates-macrophages-to-fight-抵抗-tuberculosis-bacteria.aspx<comments> https://www.news-medical.net/news/20231211/Natural-compound-activates-macrophages-to-fight-抵抗-tuberculosis-bacteria.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=e0f2159d-2707-4367-a031-d5d4f5804e53</guid><pubDate> Mon, 11 Dec 2023 11:02:47 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/3/Bacterial_infection_tuberculosis.red_cells_in_blue_background.AFB_3%2b_-_toeytoey_b32b49df7608432793064092cdd06996-620x480.jpg" width="620"><media:description><![CDATA[Natural compound activates macrophages to fight resistant tuberculosis bacteria]]></media:description></media:content></item><item><title>观察：她有一个家和一份高薪工作。然后疾病和债务颠覆了这一切。</title><description>莎朗·伍德沃德 (Sharon Woodward) 曾经作为医疗技术人员周游全国。她赚了很多钱，并对自己的技能感到自豪。</description><link/> https://www.news-medical.net/news/20231211/Watch-She-had-a-home-and-a-good-paying-job-Then-illness-and-debt-upend-it-all。 ASPX<comments> https://www.news-medical.net/news/20231211/Watch-She-had-a-home-and-a-good-paying-job-Then-illness-and-debt-upend-it-all。 aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0caff314-1741-4dad-9823-ae6c3380d5bf</guid><pubDate> Mon, 11 Dec 2023 10:48:11 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Arthritis-620x480.jpg" width="620"><media:description><![CDATA[Watch: She had a home and a good-paying job. Then illness and debt upended it all.]]></media:description></media:content></item><item><title>生物学、解剖学和金融学？更多的医学生也想要获得商业学位</title><description>近三十年前，杰森·冈德森 (Jasen Gundersen) 进入医学院成为一名农村初级保健医生时，从未考虑过从事商业职业。</description><link/> https://www.news-medical.net/news/20231211/Biology-anatomy-and-finance-More-med-students-want-business- Degrees-too.aspx<comments> https://www.news-medical.net/news/20231211/Biology-anatomy-and-finance-More-med-students-want-business- Degrees-too.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=acce9010-eb18-4ac3-b235-c8d0c5b0c445</guid><pubDate> Mon, 11 Dec 2023 10:45:50 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/6/British_GP_talking_to_senior_couple_in_surgery-Monkey_Business_Images-2000_f6030d6ad6a14fd9b5373dd78745ad65-620x480.jpg" width="620"><media:description><![CDATA[Biology, anatomy, and finance? More med students want business degrees too]]></media:description></media:content></item></channel></rss>